![]() Pearl Diagnostics Pearl Diagnostics (formerly known as MycoMed Technologies) is a company that develops diagnostic products for the detection and prevention of fungal infections. | ![]() Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | ||||
Founding Date | Founding Date 2014 | Founding Date 1999 | Founding Date 1896 | Founding Date 2000 | Founding Date 2002 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Baltimore, US HQ | Locations Loos, FR HQ Cambridge, US | Locations Amsterdam, NL HQ Villeurbanne, FR | Locations TW HQ Walnut, US | |
Employees | Employees 913% increase | Employees 180 | Employees 103,249 | Employees 133 | Employees 522% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 280.8 m | Valuation ($) N/A | Valuation ($) 38.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) €11.8m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €302k (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods €4.3m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €70.8m (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit €7.5m (FY, 2018) | Gross profit N/A |
Net income | Net income N/A | Net income (€86m) (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income (€18.5m) (FY, 2018) | Net income N/A |

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company
Esperite is a company specializing in regenerative and predictive medicine.
View companyAbnova is a biotech company specializing in antibody and protein production.
View company